Results 221 to 230 of about 75,341 (263)

Dopamine Supersensitivity Psychosis Resolved With Electroconvulsive Therapy (ECT) in a Patient With Treatment-Resistant Schizophrenia: A Case Report. [PDF]

Cureus
Takano S, Hashimoto T, Hayatsu R, Kanahara N, Nakazato M.   +4 more
europepmc   +1 more source

Dual long-acting injectable antipsychotic use in treatment-resistant schizophrenia with extensive hospitalization history: A case report. [PDF]

Ment Health Clin
Zheng L, Jhawar A.
europepmc   +1 more source

Personalized Prediction of Clozapine Treatment Response Using Therapeutic Drug Monitoring Data in Japanese Patients with Treatment-Resistant Schizophrenia. [PDF]

J Clin Med
Nakahara T, Harada Y, Nakayama N, Hashimoto K, Kida N, Onitsuka T, Noda H, Murasugi K, Takimoto Y, Omori W, Sukegawa T, Shiraishi J, Tanaka K, Maesato H, Ueno T.   +14 more
europepmc   +1 more source

A clinical control study of modified electroconvulsive therapy and sodium valproate as enhancement strategies for ultra-treatment-resistant schizophrenia. [PDF]

Schizophr Res Cogn
Wang P, Liu C, Zhu X, Yan Q, Shen N, Shi J, Lv Q, Du X.   +7 more
europepmc   +1 more source

A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case Report. [PDF]

Neuropsychopharmacol Rep
Tsukiji M, Yamazaki K, Nakata Y, Sasaki T, Idemoto K, Okada K, Yamazaki S, Omoto A, Koga K, Niitsu T, Ishii I.   +10 more
europepmc   +1 more source

Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials. [PDF]

Ther Adv Psychopharmacol
Anand R, Turolla A, Chinellato G, Sansi F, Roy A, Hartman R.   +5 more
europepmc   +1 more source

Network analysis of clinical features in patients with treatment-resistant schizophrenia. [PDF]

Front Psychiatry
Li W, Zhao J, Hu N, Zhang W.
europepmc   +1 more source

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study.

JMIR Hum Factors
Seppälä J, Grasa E, Alonso-Solis A, Roldan-Bejarano A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazán C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Reixach E, Berdun J, Usall J, Ochoa S, Corripio I, Jääskeläinen E, m-Resist Group.   +19 more
europepmc   +1 more source